Presentation Information

[[A]A304-3am-06]Biochemical features and cytotoxicity of cancer cell by Catalytic Trastuzumab capable of degrading HER2 antigen

○Moe Tsujita1, Takaaki Yahiro2,6, Hiroaki Taguchi3, Taizo Uda2,4, Emi Hifumi5,6 (1. Grad. Sch. Eng., Oita Univ., 2. Oita Univ.Med. , 3. Suzuka Univ. Med. Sci., 4. ISIT, 5. Inst. Res. Mgmt., Oita Univ., 6. Res. Cen. Glo./Loc. Inf. Disease., Oita Univ.)

Keywords:

Catalytic Antibody,HER2,Trastuzumab,Cytotoxicity